Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04080739 · ClinicalTrials.gov registry record · Phase 4
Regional Block for Postoperative Free Flap Care
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT04080739 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants.
The verdict
NCT04080739, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this protocol is to evaluate the safety and efficacy of regional anesthesia for head and neck patients undergoing microvascular free flap reconstruction.
Interventions
- DRUG ropivicaine 0.2%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-01-13 |
| Est. Completion | 2022-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04080739
The ClinicalTrials.gov registry entry for NCT04080739 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ropivicaine 0.2% is the first listed.
NCT04080739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04080739 about?
NCT04080739 is a clinical study titled "Regional Block for Postoperative Free Flap Care". The purpose of this protocol is to evaluate the safety and efficacy of regional anesthesia for head and neck patients undergoing microvascular free flap reconstruction.
What is the current status of trial NCT04080739?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2020-01-13. Estimated completion is 2022-03-01.
What interventions are being tested in trial NCT04080739?
The interventions under investigation include: ropivicaine 0.2% (DRUG).
Who is sponsoring clinical trial NCT04080739?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.